neurology Archives

016 — New MS Biosimilar, RSV Maternal Immunization, Rybrevant in Advanced NSCLC, Xtandi in Early PCa

Post author:admin
Post published:August 28, 2023
Post category:cancer genitourinary cancers infectious disease lung cancer neurology

Check out our free downloads:Implementing AMA Style – 8 Things to Get Right in Your Next ProjectNeeds Assessments – 7 Essentials for Getting FundedWorking With Your Medical Writer – 8…

009 — Leqembi, Aveir Pacemaker, Cyclophosphamide Liquid, IPX203

Post author:admin
Post published:July 10, 2023
Post category:cancer cardiology neurology

Here is information on the latest US FDA approvals, the week of July 3 – July 7, 2023. Please subscribe, rate and review this podcast. Thank you!Leqembi® Earns Regular Approval…

008 — Lantidra, Ngenla, Roctavian, Rystiggo, Skyclarys, Atorvaliq

Post author:admin
Post published:July 3, 2023
Post category:cardiology diabetes-obesity neurology rare-diseases

Here is information on the latest US FDA approvals, the week of June 26 – June 30, 2023. Please subscribe, rate and review this podcast. Thank you! Lantidra® for Type…

003 — Inpefa, Paxlovid, TheLinkBCI, Xacduro, Brixadi, Opvee

Post author:admin
Post published:May 29, 2023
Post category:cardiology diabetes-obesity infectious disease neurology ophthalmology psychiatry

Here is information on the latest US FDA approvals, the week of May 22 – May 26, 2023. Please subscribe, rate and review. Thank you!Inpefa (sotagliflozin) for heart failureThe FDA…

001 — Veozah, Rexulti, Opill, Elfabrio

Post author:admin
Post published:May 15, 2023
Post category:neurology ob-gyn-reproductive rare-diseases

Here is information on the latest US FDA approvals, the week of May 8- May 12, 2023. Please subscribe, rate and review. Thank you!Veozah (fezolinetant)The FDA has approved Veozah (fezolinetant).…